Sign In
Buy RXRX
$3.52
+0.180 (+5.39%)
At Close: Jun 26, 2026
Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors
06:51pm, Friday, 20'th Jun 2025
The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $5.03, representing a -1.57% change from its previous close.
Is This Beaten-Down Cathie Wood Artificial Intelligence (AI) Stock a Buy?
05:30am, Monday, 16'th Jun 2025
Recursion Pharmaceuticals (RXRX -5.13%) is not the most famous artificial intelligence (AI) stock on the market, but the biotech (or techbio) company has attracted the attention of some big names. Rec
Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesday
04:35pm, Tuesday, 10'th Jun 2025
In an effort to save costs and make its financial resources last longer, Recursion Pharmaceuticals (RXRX 1.49%) is slimming down and streamlining. After the biotech updated its strategy to do so on Tu
Recursion to lay off 20% of workforce, narrows focus amid biotech downturn
06:14am, Tuesday, 10'th Jun 2025
Recursion Pharmaceuticals said on Tuesday it will lay off around 20% of its workforce and focus on developing drugs for rare diseases and cancers to reduce cash burn during a prolonged biotech industr
Salt Lake City, UT, June 06, 2025 (GLOBE NEWSWIRE) -- Researchers at the Massachusetts Institute of Technology (MIT) Computer Science and Artificial Intelligence Lab (CSAIL) and Jameel Clinic, alongsi
Recursion Pharmaceuticals (RXRX) Up 5.7% Since Last Earnings Report: Can It Continue?
12:36pm, Wednesday, 04'th Jun 2025
Recursion Pharmaceuticals (RXRX) reported earnings 30 days ago. What's next for the stock?
Recursion to Participate in Upcoming Investor Conferences
08:00am, Friday, 30'th May 2025
Salt Lake City, May 30, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in th
Recursion to Participate in Upcoming Investor Conferences
08:00am, Friday, 30'th May 2025
Salt Lake City, May 30, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in th
RXRX vs. SDGR: Which AI-Powered Drug Discovery Stock Has More Upside?
11:01am, Tuesday, 27'th May 2025
Recursion Pharmaceuticals and Schrodinger leverage their respective AI drug discovery platforms to potentially develop distinguished therapeutic candidates.
3 Monster Stocks to Hold for the Next 10 Years
08:05pm, Monday, 26'th May 2025
Most investors are best served by owning high-quality "forever" stocks, even if these stocks are only apt to produce average returns.
Recursion Pharmaceuticals Plunges 22% in May: How to Play the Stock
10:45am, Thursday, 15'th May 2025
Despite the current downward trend of RXRX, one should retain the stock for long-term gains due to the significant potential of its AI-driven drug discovery technology.
Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?
04:18am, Monday, 12'th May 2025
Artificial intelligence (AI) has taken over Wall Street. The leaders in this rapidly growing field are attracting significant attention.
2 Top Artificial Intelligence (AI) Stocks to Buy Right Now
08:00am, Sunday, 11'th May 2025
The artificial intelligence (AI) revolution is reshaping our world at an unprecedented pace. As AI technology evolves, it's set to fundamentally transform countless industries through enhanced automat
Why Recursion Pharmaceuticals Stock Plummeted 24% This Week
05:17pm, Friday, 09'th May 2025
Shares of Recursion Pharmaceuticals (RXRX -1.48%) fell this week. The stock lost 24% as of market close on Friday.
Why Recursion Pharmaceuticals Stock Is Plummeting Today
03:09pm, Tuesday, 06'th May 2025
Shares of Recursion Pharmaceuticals (RXRX -11.15%) are tumbling on Tuesday. The stock lost 10.3% as of 2:50 p.m.
